Pure Global

Vital USA Respiratory Rate Validation In Adults - Trial NCT04292639

Access comprehensive clinical trial information for NCT04292639 through Pure Global AI's free database. This phase not specified trial is sponsored by Vital USA, Inc. and is currently Completed. The study focuses on Respiratory Complication. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT04292639
Completed
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT04292639
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Vital USA Respiratory Rate Validation In Adults
Final Test Report for Vital USA Respiratory Rate Validation In Adults

Study Focus

Respiratory Complication

The Vital Detect Pulse Oximeter

Interventional

device

Sponsor & Location

Vital USA, Inc.

Louisville, United States of America

Timeline & Enrollment

N/A

Dec 17, 2019

Dec 20, 2019

20 participants

Primary Outcome

Respiratory Rate Accuracy Validation for the Vital USA Vital Detect Monitor.

Summary

Vital USA is dedicated to developing and applying innovative electronic medical solutions
 that improve patient care in multiple clinical settings. Vital USA is a manufacturer of a
 multi-parameter patient monitor that is intended to be used in a variety of medical settings
 including hospitals, medical offices and patients' homes.

ICD-10 Classifications

Respiratory disorder, unspecified
Other respiratory disorders
Respiratory failure, unspecified
Other postprocedural respiratory disorders
Other specified respiratory disorders

Data Source

ClinicalTrials.gov

NCT04292639

Device Trial